Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women

Summary

This study seeks to understand the immune cells in the cervical fluid of in the blood and genital tract of HIV-negative healthy female volunteers and to see if these cells can be modified using a combined anti-viral and antiinflammatory drug called maraviroc, a medicine used in the treatment of HIV infection.

Timeline

Start

2015-01

Primary completion

2016-10-28

Completion

2016-10-28

Outcome

Outcome not reported

Stopped: “Minimal efficacy of maraviroc alone was found in preliminary data analysis of another study.”

Drugs

Indications